1. Home
  2. QLGN vs ASTC Comparison

QLGN vs ASTC Comparison

Compare QLGN & ASTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QLGN
  • ASTC
  • Stock Information
  • Founded
  • QLGN 1996
  • ASTC 1984
  • Country
  • QLGN United States
  • ASTC United States
  • Employees
  • QLGN N/A
  • ASTC N/A
  • Industry
  • QLGN Biotechnology: Pharmaceutical Preparations
  • ASTC Biotechnology: Laboratory Analytical Instruments
  • Sector
  • QLGN Health Care
  • ASTC Industrials
  • Exchange
  • QLGN Nasdaq
  • ASTC Nasdaq
  • Market Cap
  • QLGN 7.4M
  • ASTC 7.1M
  • IPO Year
  • QLGN N/A
  • ASTC 1995
  • Fundamental
  • Price
  • QLGN $3.06
  • ASTC $4.17
  • Analyst Decision
  • QLGN
  • ASTC
  • Analyst Count
  • QLGN 0
  • ASTC 0
  • Target Price
  • QLGN N/A
  • ASTC N/A
  • AVG Volume (30 Days)
  • QLGN 3.7M
  • ASTC 1.6M
  • Earning Date
  • QLGN 11-13-2025
  • ASTC 11-11-2025
  • Dividend Yield
  • QLGN N/A
  • ASTC N/A
  • EPS Growth
  • QLGN N/A
  • ASTC N/A
  • EPS
  • QLGN N/A
  • ASTC N/A
  • Revenue
  • QLGN N/A
  • ASTC $1,049,000.00
  • Revenue This Year
  • QLGN N/A
  • ASTC N/A
  • Revenue Next Year
  • QLGN N/A
  • ASTC N/A
  • P/E Ratio
  • QLGN N/A
  • ASTC N/A
  • Revenue Growth
  • QLGN N/A
  • ASTC N/A
  • 52 Week Low
  • QLGN $1.61
  • ASTC $3.75
  • 52 Week High
  • QLGN $8.81
  • ASTC $8.15
  • Technical
  • Relative Strength Index (RSI)
  • QLGN 40.62
  • ASTC 41.97
  • Support Level
  • QLGN $2.90
  • ASTC $3.89
  • Resistance Level
  • QLGN $5.97
  • ASTC $4.29
  • Average True Range (ATR)
  • QLGN 0.54
  • ASTC 0.28
  • MACD
  • QLGN -0.20
  • ASTC -0.01
  • Stochastic Oscillator
  • QLGN 5.21
  • ASTC 30.00

About QLGN Qualigen Therapeutics Inc.

Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's program, QN-302, is an investigational small-molecule G-quadruplexes (G4)-selective transcription inhibitor with binding affinity to G4s prevalent in cancer cells.

About ASTC Astrotech Corporation (DE)

Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.

Share on Social Networks: